# Acclinate

> Acclinate is a Birmingham, Alabama digital health-equity company that helps drug makers put more Black and other underrepresented people into clinical trials. It runs NOWINCLUDED, a community health platform with 200,000-plus members, and feeds that consented, first-party engagement data into e-DICT, a patented predictive-analytics engine that tells pharma who is both eligible for a trial and actually likely to join. The bet: fix the biased data at the source, then sell the auditable diversity numbers regulators now demand.

- **Founded:** 2020
- **Headquarters:** Birmingham, Alabama, United States
- **Founders:** Del Smith (Co-Founder & CEO), Tiffany Whitlow (Co-Founder & Chief Development Officer)
- **Team size:** ~54
- **Products:** NOWINCLUDED, e-DICT (Enhanced Diversity in Clinical Trials), Clinical trial diversity consulting
- **Notable:** Named to the Inc. 5000 in 2024 and 2025 - in 2025 ranked #3 in Birmingham, #6 in Alabama and #9 in US healthcare., Reported a 3.8x increase in participants identifying as Black/African American in Alzheimer's research., Grew NOWINCLUDED to 200,000-plus community members.

## Products & services

- **NOWINCLUDED** — A B2C community health platform created by and for the Black/African American community, offering health education, resources and engagement around conditions that disproportionately affect communities of color. 200,000-plus members, and the consented, authenticated data source that feeds e-DICT.
- **e-DICT (Enhanced Diversity in Clinical Trials)** — A patented, HIPAA-compliant predictive-analytics and machine-learning engine that identifies trial-eligible individuals most likely to participate and gives sponsors real-time reporting on community access, engagement and diversity. It is the only engine trained on authenticated community data from NOWINCLUDED, and includes a patent-pending Participation Probability Index.
- **Clinical trial diversity consulting** — Advisory services for pharmaceutical sponsors and CROs on inclusive trial design, site selection, community activation and regulatory diversity strategy.

## Achievements

- Named to the Inc. 5000 in 2024 and 2025 - in 2025 ranked #3 in Birmingham, #6 in Alabama and #9 in US healthcare.
- Reported a 3.8x increase in participants identifying as Black/African American in Alzheimer's research.
- Grew NOWINCLUDED to 200,000-plus community members.
- Reportedly serves 7 of the top 10 US pharmaceutical companies.
- Co-founder Tiffany Whitlow named to Inc. Female Founders 500 (2026) and Top 250 Female Founder (2022).
- Google for Startups Black Founders alumni; CEO met with Sundar Pichai.
- Raised approximately $15.5M in total funding.

## Latest updates

- **2026-02** — Closed a $3.5M debt financing round.
- **2026-01** — Co-founder Tiffany Whitlow named to Inc.'s Female Founders 500 list.
- **2025-09** — Named to the Inc. 5000 for a second consecutive year - #9 in US healthcare.
- **2025-06** — Released its 2025 Annual Impact Report.
- **2024-05** — Raised a $7M Series A led by Cencora Ventures, with Labcorp and Latimer Ventures.

## Links

- Website: https://www.acclinate.com
- LinkedIn: https://www.linkedin.com/company/acclinateinc/
- Twitter/X: https://x.com/accgenetics
- Facebook: https://facebook.com/Acclinate/

---

Profile page: https://yespress.io/acclinate
Published by YesPress — https://yespress.io
Last updated: 2026-08-19